Search Results

You are looking at 1 - 5 of 5 items for

  • Author or Editor: Manmohan Singh x
Clear All Modify Search
Full access

Govindaraju Lakshmi Prasad, Manish Singh Sharma, Shashank S. Kale, Deepak Agrawal, Manmohan Singh and Bhawani Shankar Sharma

OBJECTIVE

Of the intracranial schwannomas, those arising from the vestibular nerves are the most common. Abducens nerve (AN) schwannomas are very rare, and there is limited literature on their optimal management. Therapeutic options include surgery and/or stereotactic radiosurgery. The aim of this study was to evaluate the role of Gamma Knife radiosurgery (GKRS) in these sixth cranial nerve (CN) schwannomas.

METHODS

The authors performed a retrospective analysis of patients who had undergone GKRS for intracranial tumors at their institute in the period from 2003 to 2010. Inclusion criteria were as follows: isolated AN paresis on presentation, a lesion along the course of the sixth CN, and imaging features characteristic of a schwannoma. Patients with other CN deficits and neurofibromatosis Type 2 were excluded. Symptomatic improvement was defined as the resolution of or an improvement in diplopia noted on a subjective basis or as an improvement in lateral eyeball excursion noted objectively on follow-up. A reduction in tumor volume by at least 20%, as noted by comparing the pre- and post-GKRS images, was deemed significant.

RESULTS

Six patients with a mean age of 37.1 years (range 17–55 years) underwent primary GKRS. There were 2 prepontine cistern, 3 cavernous sinus, and 1 cisterno-cavernous tumor. The mean duration of symptoms was 6.1 months (range 3–12 months). The mean tumor volume was 3.3 cm3 (range 1.5–4.8 cm3). The mean tumor margin radiation dose was 12.5 Gy (range 12–14 Gy), while the median margin dose was 12 Gy (50% isodose line). The median number of isocenters used was 5 (range 4–8). The brainstem received an average 8.35-Gy radiation dosage (range 5.5–11 Gy). The mean follow-up duration was 44.3 months (range 24–78 months). Symptoms remained stable in 1 patient, improved in 3, and resolved in 2 (total improvement 83%). Magnetic resonance imaging at the last follow-up showed a stable tumor size in 3 patients (50%) and a reduction in the other 3. Thus, the tumor control rate achieved was 100%. No new CN deficits were noted.

CONCLUSIONS

Abducens nerve schwannomas are rare intracranial tumors. They can be cavernous, cisternal, or cisterno-cavernous in location. Excellent tumor control rates and symptomatic improvement can be achieved with GKRS, which appears to be a safe and effective, minimally invasive modality for the treatment of such lesions. Therefore, it is reasonable to consider GKRS as the initial treatment of choice for this rare pathology. Long-term follow-up will be essential for further recommendations.

Free access

Sanjeev Ariyandath Sreenivasan, Kanwaljeet Garg, Shashwat Mishra, Pankaj Kumar Singh, Manmohan Singh and Poodipedi Sarat Chandra

Restricted access

Kanwaljeet Garg, Ankita Aggarwal and Manmohan Singh

Free access

Sanjeev Ariyandath Sreenivasan, Kanwaljeet Garg, Shashwat Mishra, Pankaj Kumar Singh, Manmohan Singh and Poodipedi Sarat Chandra

Restricted access

Sanjeev Ariyandath Sreenivasan, Kanwaljeet Garg, Manmohan Singh and Poodipedi Sarat Chandra